Alerts will be sent to your verified email
Verify Email
GUJTHEM
|
Guj. Themis Biosyn
|
Concord Biotech
|
Medicamen Biotech
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
34.65 % | 19.73 % | 8.49 % |
|
5yr Avg Net Profit Margin
|
35.51 % | 30.4 % | 10.0 % |
|
Price to Book
|
16.86 | 9.73 | 2.2 |
|
P/E
|
93.91 | 49.5 | 49.41 |
|
5yr Avg Cash Conversion Cycle
|
-112.39 Days | 76.63 Days | 13.14 Days |
|
5yr Average Interest Coverage Ratio
|
216.76 | 195.92 | 10.36 |
|
5yr Avg ROCE
|
45.66 % | 25.76 % | 12.12 % |
|
5yr Avg Operating Profit Margin
|
47.34 % | 43.43 % | 16.84 % |
|
5 yr average Debt to Equity
|
0.03 | 0.03 | 0.14 |
|
5yr CAGR Net Profit
|
10.07 % | 9.62 % | -6.51 % |
|
5yr Average Return on Assets
|
26.69 % | 16.36 % | 5.75 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
70.86 % | 44.08 % | 40.46 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-4.13 % | 0.0 | -3.14 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
1.14 % | -0.9 % | 0.0 |
|
Guj. Themis Biosyn
|
Concord Biotech
|
Medicamen Biotech
|
|---|